The Impact of Preoperative Supplementation of Zinc

1. Pre operative anthropometric assessment including : weight in kg, height/length and BMI 2. Pre operative Zinc supplementation (dose according to the age) for 7 days preoperatively for cases 3. Postoperative data collection

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgery Nutrition Disorders Nutritional and Metabolic Diseases

Age range

1 month–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hoda Atef Abdelsattar Ibrahim

Cairo, Egypt

About this study

Postoperative data collection :

Length of hospital stay
Complication and sorting of them
Lab withdrawal of inflammatory markers on 2-3 day postoperatively

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All children patients with Hirschsprung disease admitted for surgical intervention with different ( age , sex )
Type of surgery : transanal pull through
Whose parents or caregivers approve for the participation in the study

Exclusion criteria

Patients with emergency situations
Whose parents or caregivers will not apply for the participation in the study

Treatment and study plan

Zinc

Dietary Supplement

Zinc Supplementation

Primary outcomes

The effect of preoerative Zinc supplementation on the hospital length stay in children operated for Hirschsprung's disease

Time frame: zinc supplemenation for one week

Children oprated for elective surgery for Hirschsprung's disease will be supplemented with zinc seven days before surgery and postoperative data as the duration of hospital length stay in hours will be meausred in both the cases and control groups and comapred.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

The Impact of Preoperative Supplementation of Zinc on Post-operative Outcomes in Children Undergoing Elective Surgery for Hirsch Sprung Disease

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Mar 27, 2023
Registry last updated: Feb 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed